Cohen Noble Prize for Acorda 2.0













Looks like the Nobel committee decided to honor the scientists who discovered microRNA as opposed to the charlatan wBho couldn’t manage a micro cap company.

It’s hard to imagine that a generic product with no use didn’t rank up there in the voting.
BASHING OUR GREAT CEO IS DISRESPECT! THE NOBEL WAS HIS BUT THE BIG PHARMA INDUSTRIAL COMPLEX ALINED AGAINST HIM! ALL THE PR IN WORLD COULD NOT STOP THIS !! ACOR A VICTIM OF ITS OWN SUCESS ! MAYBE NEXT YEAR !
 






BASHING OUR GREAT CEO IS DISRESPECT! THE NOBEL WAS HIS BUT THE BIG PHARMA INDUSTRIAL COMPLEX ALINED AGAINST HIM! ALL THE PR IN WORLD COULD NOT STOP THIS !! ACOR A VICTIM OF ITS OWN SUCESS ! MAYBE NEXT YEAR !
YOU SO CORRECT OUR PRECIOUS HABIBI, OUR FLOWER OF ACORDION DESERT.
SO MUCH DISRESPECT FLOWS IN THIS PHARMA WORLD. SO MUCH JEALOUSY ABOUT THE ACORDION'S SUCCESS.
BUT NO WORRIES LIKE A RADIANT PHOENIX IT WILL ARISE AGAIN!!!
 












YOU SO CORRECT OUR PRECIOUS HABIBI, OUR FLOWER OF ACORDION DESERT.
SO MUCH DISRESPECT FLOWS IN THIS PHARMA WORLD. SO MUCH JEALOUSY ABOUT THE ACORDION'S SUCCESS.
BUT NO WORRIES LIKE A RADIANT PHOENIX IT WILL ARISE AGAIN!!!
Habib

Bankruptcy is not success. $40M in revenue off a $700M forecast is not success.

The Nobel committee recognizes innovation not participation.
 






Habib

Bankruptcy is not success. $40M in revenue off a $700M forecast is not success.

The Nobel committee recognizes innovation not participation.
PR TEAM ALSO RECOGNISE THAT INNOVATION IMPORTANT TO NOBEL AND ACORDA HAS HAD MANY!! AND A CEO LEADING THE R&D PIPE TO WORLD CLASS PD MED INNOVATION.! SAVE MILLION OF LIFES !! BIG PHARMA YES AFRAID OF SMALL PHARMA ! NOBEL WILL FOLLOW NEXT YEAR WITH MIGHTY PR PUSH !!
 






PR TEAM ALSO RECOGNISE THAT INNOVATION IMPORTANT TO NOBEL AND ACORDA HAS HAD MANY!! AND A CEO LEADING THE R&D PIPE TO WORLD CLASS PD MED INNOVATION.! SAVE MILLION OF LIFES !! BIG PHARMA YES AFRAID OF SMALL PHARMA ! NOBEL WILL FOLLOW NEXT YEAR WITH MIGHTY PR PUSH !!
Habib

Large Pharma buys small Pharma except in the case of lowly ACOR where even they saw no upside for commercial or pipeline products.

Given that MeTooDopa was a palliative med with minimal to no use, I’d town down the typical Pharma mantra of saving lives. At best you cost a few payers a bunch of money for a modified generic.

Maybe Reverse Gear Ronnie can get a Nobel for innovative ways to BS the investment community
 






Poster #88
You so wrong
MERZ, a large Pharma, acquired Acorda's innovative products.
CATALENT, a large Pharma formulation company, bought the Arcus technology.

Correct your misinformation and only SPEAK THE TRUTH!

That is the least you can do as a good Christian running a virtual crusade against Habib and his goat-lover types.
 






Poster #88
You so wrong
MERZ, a large Pharma, acquired Acorda's innovative products.
CATALENT, a large Pharma formulation company, bought the Arcus technology.

Correct your misinformation and only SPEAK THE TRUTH!

That is the least you can do as a good Christian running a virtual crusade against Habib and his goat-lover types.
Habib

Metz is a POS family owned company no one has ever heard of. It’s not like BMS, PFE, MRK or NVS bought out ACOR for billions. Enough money changed hands to close out some debt. Period.

Catalent bought manufacturing capacity nothing more. That deal was the signal that even Rikers Ronnie didn’t believe in the future of his generic product. If there was a market, it made more sense to be as vertically integrated as possible.

ACOR was the modern day equivalent of a sailing vessel run aground, throwing off anything they could to try and reflows the ship.
 






Habib

Metz is a POS family owned company no one has ever heard of. It’s not like BMS, PFE, MRK or NVS bought out ACOR for billions. Enough money changed hands to close out some debt. Period.

Catalent bought manufacturing capacity nothing more. That deal was the signal that even Rikers Ronnie didn’t believe in the future of his generic product. If there was a market, it made more sense to be as vertically integrated as possible.

ACOR was the modern day equivalent of a sailing vessel run aground, throwing off anything they could to try and reflows the ship.
BEG TOO DISAGREE AS METZ IS A WORLD CLASS PHARMA NO BS COMPANY !! SO STOP BS TRAP!! ALSO ACOR INTELLECTUAL PROPERTY WAS HOT TOPIC WITH A BIDDING WAR BY BIG PHARMA! GUESS THAT THE PIPE WAS LOADED WITH WINNERS AFTER ALL ! DR RC AN THE PR TEAM WELL AWARE OF THE WEALTH AN MANY OTHER ALSO !!
 






BEG TOO DISAGREE AS METZ IS A WORLD CLASS PHARMA NO BS COMPANY !! SO STOP BS TRAP!! ALSO ACOR INTELLECTUAL PROPERTY WAS HOT TOPIC WITH A BIDDING WAR BY BIG PHARMA! GUESS THAT THE PIPE WAS LOADED WITH WINNERS AFTER ALL ! DR RC AN THE PR TEAM WELL AWARE OF THE WEALTH AN MANY OTHER ALSO !!
Habib

You thought ACOR was world class and MeTooDopa was a blockbuster, so your ignorance of the insignificance of both Merz and the acquisition can be excused.

As for your fantasy bidding war, Merz bought the product with the technology, the manufacturing was sold off to keep Ronnie afloat and the pipeline was all on hold due to lack of money, lack of interest in the technology and late to market indications.

It is good that RC is aware of his wealth as it will be a point of discussion with regulators since it was gained by lying to investors.
 










































Good point. Bottom Line - Dr Cohen got blindsighted by the interns who did sloppy work and Dr Cohens staff did not manage them properly. We now know the rest of the story and see why Dr Cohen is so highly regarded in the bio pharma world. Kudos Dr Cohen !!
Highly regarded in Pharma???? This is an individual that was at the head position of 2 public companies that he managed to bankruptcy, and destroyed Billions in value…One of the key responsibilities of a CEO is created shareholder value…. HE FAILED